Clinical trials
Phase 1 Heart Failure trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
13 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2016 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 2 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 5 |
| Recruiting | 3 |
| Unknown status | 3 |
| Not yet recruiting | 1 |
| Suspended | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Beijing Suncadia Pharmaceuticals Co., Ltd | 2 |
| Anhui HygeianCells BioMedical Co., Ltd. | 1 |
| Chengdu Suncadia Medicine Co., Ltd. | 1 |
| HELP Therapeutics Co., Ltd. | 1 |
| Hebei Medical University | 1 |
| RenJi Hospital | 1 |
| Ruijin Hospital | 1 |
| Second Affiliated Hospital, Zhejiang University, School of Medicine | 1 |
| Shandong Suncadia Medicine Co., Ltd. | 1 |
| Shanghai East Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Heart Failure | 13 |
| Cardiomyopathy, Dilated | 3 |
| Cardiomyopathies | 1 |
| Cardiovascular Diseases | 1 |
| Coronary Artery Disease | 1 |
Trials
Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.